A multicenter, fixed-flexible dose study of terazosin hydrochloride in the treatment of symptomatic benign prostatic hypertrophy

A multicenter, fixed-flexible dose study of terazosin hydrochloride in the treatment of symptomatic benign prostatic hypertrophy

In this study the multicenter, fixed-flexible dose regimen was taken to evaluate the effective dose range of Terazosin for the treatment of micturition disturbance in benign prostatic hypertrophy (BPH) and to clarify the characteristics of patients who are more responsive to Terazosin therapy. After...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 38(1992), 7 vom: 01. Juli, Seite 857-68
1. Verfasser: Park, Y C (VerfasserIn)
Weitere Verfasser: Nishioka, T, Arai, Y, Tomoyoshi, T, Kurita, T, Hayashida, H, Nagai, N, Inoue, H, Kataoka, K, Kitagawa, Y
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1992
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial English Abstract Journal Article Multicenter Study Adrenergic alpha-Antagonists Terazosin 8L5014XET7 Prazosin XM03YJ541D